Nanjing Pharmaceutical Group Company Limited (SHA:600713)

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Wholesale	50.73B
Wholesale Growth	6.35%
Retail	2.33B
Retail Growth	15.07%
E-Commerce	392.41M
E-Commerce Growth	19.53%
Franchise Service	28.66M
Franchise Service Growth	28.34%
Warehousing and Logistics	26.15M
Warehousing and Logistics Growth	10.87%
Other	30.88M
Other Growth	-57.59%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	53.59B
China Growth	6.71%